Randomized, Double-blind, Parallel-group, Phase 1 Study.

Trial Profile

Randomized, Double-blind, Parallel-group, Phase 1 Study.

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Jan 2016

At a glance

  • Drugs Infliximab (Primary)
  • Indications Ankylosing spondylitis
  • Focus Pharmacokinetics; Registrational
  • Acronyms PLANETAS
  • Sponsors Celltrion
  • Most Recent Events

    • 13 Jun 2015 Results of retrospective analysis of pooled data from PLANETAS and PLANETRA trials presented at the 16th Annual Congress of the European League Against Rheumatism.
    • 30 Oct 2013 Efficacy results presented at the 77th American College of Rheumatology and the 48th Annual Meeting of the Association of Rheumatology and Health Professionals.
    • 15 Jun 2013 Results presented at the 14th Annual Congress of the European League Against Rheumatism.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top